Results 191 to 200 of about 10,368 (217)

Age-specific efficacy of biologics in severe asthma: a pediatric perspective. [PDF]

Front Allergy
Andrenacci B, Calciano F, Madini B, Rocchi A, Ghiglioni DG, Maffeis L, Patria MF, Licari A, Marseglia GL.   +8 more
europepmc   +1 more source

Treatment patterns of eosinophilic esophagitis in the biologic era-a real-world analysis. [PDF]

Dis Esophagus
Pokryszka J, Weitersberger M, Dinkhauser P, Steidl K, Horvatits T, Haefner M, Kazemi-Shirazi L, Novacek G, Trauner M, Sieghart W, Schlager H, Schreiner P.   +11 more
europepmc   +1 more source

Tissue eosinophilia suggests dupilumab treatment response in chronic rhinosinusitis with nasal polyps (CRSwNP). [PDF]

Eur Arch Otorhinolaryngol
Huber P, Braunschweig T, Frankenberger H, Stihl C, Gröger M, Gellrich D, Lasch M.   +6 more
europepmc   +1 more source

Evaluation of Outcomes of Dupilumab Therapy in Patients with Atopic Dermatitis - A Single-Center Retrospective Longitudinal Study.

Indian J Dermatol
Miniello A, Pugliese F, Pepe I, Pastore G, Lassandro M, Calabrese C, Nettis E.   +6 more
europepmc   +1 more source

Detection and Management of Eosinophilia in Asthmatic Adults and Children Receiving Dupilumab Treatment: A Focused Review. [PDF]

J Inflamm Res
Caminati M, Cefaloni F, Tenero L, De Corso E, Micheletto C, Piacentini G.   +5 more
europepmc   +1 more source

Efficacy of Biological and Steroid Therapies in Adolescent and Adult Patients With Eosinophilic Esophagitis: A Systematic Review and Network Meta-Analysis With Meta-Regression. [PDF]

Clin Gastroenterol Hepatol
Al Hayek M, Lucendo AJ, Savarino EV, Barberio B, Gyawali CP, Chan WW, Visaggi P, Najah Q, Yadlapati R, McCoul ED, Elhadi M, Laine L.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Dupilumab

Reactions Weekly
  +23 more sources

Dupilumab

Reactions Weekly, 2022
  +8 more sources

Dupilumab

Reactions Weekly, 2023
  +8 more sources